The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome

1. Arias-Pulido, H.
2. Cimino-Mathews, A.
3. Chaher, N.
4. Qualls, C.
5. Joste, N.
6. Colpaert, C.
7. Marotti, J.D.
8. Foisey, M.
9. Prossnitz, E.R.
10. Emens, L.A.
11. Fiering, S.